Jesse J Geiger
CIK 1677399 · View on SEC EDGAR ↗
First SEC filing: Aug. 10, 2016 · Latest: Aug. 10, 2016
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 14, 2021 | MEDP | S | 3,000 | $180.00 | $540,000 | 6,382 Direct | -31.98% | Disposed | 243.2% (price as of 2026-08-20) |
| Dec. 20, 2019 | MEDP | S 10b5-1 | 16,948 | $84.00 | $1,423,632 | 0 Direct | -100.00% | Disposed | 635.4% (price as of 2026-08-20) |
| Dec. 19, 2019 | MEDP | S 10b5-1 | 14,400 | $82.00 | $1,180,800 | 16,948 Direct | -45.94% | Disposed | 653.4% (price as of 2026-08-20) |
| Aug. 2, 2018 | MEDP | S | 7,407 | $60.15 | $445,531 | 0 Direct | -100.00% | Disposed | 927.0% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 14, 2021 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (3,000) | $28.32 | March 15, 2024 | 3,000 | Disposed |
| Feb. 28, 2018 | MEDP | Employee Stock Option (Right to Buy) | Common Stock (15,000) | $32.05 | Feb. 28, 2025 | 15,000 | Acquired |
| March 15, 2017 | MEDP | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | COMMON STOCK (20,000) | $28.32 | March 15, 2024 | 20,000 | Acquired |
| Aug. 10, 2016 | MEDP | EMPLOYEE STOCK OPTION (RIGHT TO BUY) | Common Stock (18,510) | $23.00 | Aug. 10, 2023 | 18,510 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 10, 2016 | MEDP | Employee Stock Option (right to buy)→ Common Stock (48,148) | 48,148 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
MEDP
President| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $641,667 | $240,700 | — | — | — | — | $14,000 | $2,396,370 |
| 2024 | $606,667 | $318,600 | — | — | — | — | $13,800 | $4,709,067 |
| 2023 | $549,250 | $384,578 | — | — | — | — | $11,250 | $945,078 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.